Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Place of surgery before and after concurrent chemoradiotherapy for locally advanced cervical carcinoma: A retrospective study of 102 cases].
Lavoué V, Voguet L, Bertel C, Mesbah H, Williaume D, Laguerre B, Porée P, Foucher F, Montpetit E, Leblanc M, Levêque J. Lavoué V, et al. Among authors: laguerre b. J Gynecol Obstet Biol Reprod (Paris). 2011 Feb;40(1):11-21. doi: 10.1016/j.jgyn.2010.10.008. Epub 2010 Nov 30. J Gynecol Obstet Biol Reprod (Paris). 2011. PMID: 21123006 Free article. French.
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Tubiana-Mathieu N, Cany L, Catala S, Khayat D, Pauporté I, Kramar A; PHARE trial investigators. Pivot X, et al. Lancet Oncol. 2013 Jul;14(8):741-8. doi: 10.1016/S1470-2045(13)70225-0. Epub 2013 Jun 11. Lancet Oncol. 2013. PMID: 23764181 Clinical Trial.
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France.
Houédé N, Beuzeboc P, Gourgou S, Tosi D, Moise L, Gravis G, Delva R, Fléchon A, Latorzeff I, Ferrero JM, Oudard S, Tartas S, Laguerre B, Topart D, Roubaud G, Agherbi H, Rebillard X, Azria D. Houédé N, et al. Among authors: laguerre b. BMC Cancer. 2015 Apr 4;15:222. doi: 10.1186/s12885-015-1257-2. BMC Cancer. 2015. PMID: 25884302 Free PMC article.
Intérêt de la surveillance scannographique après cystectomie pour cancer.
Peyronnet B, Alimi Q, Mathieu R, Laguerre B, Vauleon E, Vincendeau S, Manunta A, Guille F, Rioux-Leclercq N, Bensalah K, Verhoest G. Peyronnet B, et al. Among authors: laguerre b. Prog Urol. 2014 Nov;24(13):808. doi: 10.1016/j.purol.2014.08.057. Epub 2014 Oct 30. Prog Urol. 2014. PMID: 26461583 French. No abstract available.
Clinical Benefit of Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma: The French Retrospective SECTOR Study.
Oudard S, Joly F, Geoffrois L, Laguerre B, Houede N, Barthelemy P, Gross-Goupil M, Vano Y, Lucidarme O, Bidault F, Kelkouli N, Slimane K, Escudier B. Oudard S, et al. Among authors: laguerre b. Clin Genitourin Cancer. 2016 Dec;14(6):e595-e607. doi: 10.1016/j.clgc.2016.04.019. Epub 2016 May 2. Clin Genitourin Cancer. 2016. PMID: 27283478
126 results